Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients.

Muratori, Francesco; Greto, Daniela; Cenatiempo, Mauro; Mazzei, Giacomo; Frenos, Filippo; Roselli, Giuliana; Livi, Lorenzo; Capanna, Rodolfo et al. · J Orthop · 2019

retrospective_cohort · Level III

Where this comes from

Record sourced from PubMed, PMID 30976144.
Also identified by DOI 10.1016/j.jor.2019.03.004 and PMC identifier 6441716.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

The Authors reported a retrospective study of 100 Leiomyosarcoma (LMS), evaluating factors that may influence Overall Survival (OS), Local Recurrence Free Survival (LRFS), Metastasis Free Survival (MFS). Tumor Size (P = 0,0009), Local Recurrence (P = 0,0487), Distant relapse (P < 0,0001), Type of Presentation (P = 0,0213) were significant risk factors affecting overall survival (OS). Tumor Size (P = 0.024), age at diagnosis (P = 0,0086), type of presentation (P < 0,0001) and Local Recurrence (P = 0.0152) affected metastasis free survival (MFS). Type of presentation (P = 0,001) was an independent prognostic factor of local recurrence-free survival (LRFS).

Read the full text

View on PubMed · Publisher (DOI)